[1] de Boer YS, Kosinski AS, Urban TJ, et al. Features of autoimmune hepatitis in patients with drug-induced liver injury. Clin Gastroenterol Hepatol, 2017, 15:103-112.e2.
[2] Reuben A, Koch DG, Lee WM, Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology, 2010, 52:2065-2076.
[3] Lee KW, Chan SL. Hepatotoxicity of targeted therapy for cancer. Expert Opin Drug Metab Toxicol, 2016, 12:789-802.
[4] Takeda M, Okamoto I, Nakagawa K. Pooled safety analysis of EGFR-TKI treatment for EGFR mutation-positive non-small cell lung cancer. Lung Cancer, 2015, 88:74-79.
[5] Teschke R, Schwarzenboeck A, Eickhoff A, et al. Clinical and causality assessment in herbal hepatotoxicity. Expert Opin Drug Saf, 2013, 12:339-366.
[6] Navarro VJ, Barnhart H, Bonkovsky HL, et al. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology, 2014, 60:1399-1408.
[7] Medina-Caliz I, Robles-Diaz M, Garcia-Mu?oz B, et al. Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury. J Hepatol, 2016, 65:532-542.
[8] Atienzar FA, Blomme EA, Chen M, et al. Key challenges and opportunities associated with the use of in vitro models to detect human DILI: integrated risk assessment and mitigation plans. Biomed Res Int, 2016, 2016:9737920.
[9] Chen M, Suzuki A, Thakkar S, et al. DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug Discov Today, 2016, 21:648-653.
[10] Metushi IG Sanders C; Acute Liver Study Group, et al. Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced liver failure. Hepatology, 2014, 59:1084-1093.
[11] Gao H, Ruan JQ, Chen J, et al.Blood pyrrole-protein adducts as a diagnostic and prognostic index in pyrrolizidine alkaloid-hepatic sinusoidal obstruction syndrome.Drug Des Devel Ther, 2015, 9:4861-4868.
[12] Björnsson E, Aithal G.Immune-mediated drug-induced liver injury//Gershwin ME, Vierling JM, Manns MP. Liver immunology. Berlin: Springer International Publishing, 2014:401-412. |
